Thank you for visiting us. We are currently updating our shopping cart and regret to advise that it will be unavailable until September 1, 2014. We apologise for any inconvenience and look forward to serving you again.

Print this page Share

Biomarkers in Heart Disease

James de Lemos (Editor)
ISBN: 978-1-4051-7571-5
256 pages
May 2008, Wiley-Blackwell
Biomarkers in Heart Disease (1405175710) cover image
Biomarkers in Heart Disease is the first title in the AHA Clinical Series and is aimed at meeting the needs of clinicians, providing cardiologists, internists, emergency physicians, laboratorians, and other healthcare providers with a clear understanding of the role of biomarkers in contemporary cardiovascular medicine.

The book covers both the strengths and pitfalls of currently available markers, and provides information on the most promising biomarkers that are likely to impact practice in the next few years. It is divided into four parts, organized around clinical scenarios rather than individual biomarkers.

This book will help the practicing physician decide which biomarkers to measure, when to measure them, how to interpret the results and how to make decisions based on the test result.

See More
Part I Biomarkers for the Evaluation of Patients with Ischemic Heart Disease.

1 Protocols for Diagnosing Myocardial Infarction.

2 Troponin and Other Markers of Necrosis for Risk Stratification in Patients with Acute Coronary Syndromes.

3 Challenges Interpreting Cardiac Troponin Values.

4 Natriuretic Peptides and Inflammatory Markers for Risk Stratification in Patients with Ischemic Heart Disease.

5 Novel Markers in Patients with Suspected ACS.

Part II Biomarkers for Evaluation of Patients with Heart Failure.

6 Use of Natriuretic Peptides in the Diagnosis of Heart Failure.

7 Biomarkers for Risk Stratification in Patients with Heart Failure.

8 Natriuretic Peptides for Disease Monitoring in Patients with Chronic Heart Failure.

Part III Biomarkers for Screening in the Ambulatory Populations.

9 CRP.

10 Newer Markers for Population Screening.

Part IV A Look to the Future.

11 Moving Toward Personalized Medicine.

See More
James de Lemos, MD, Associate Professor of Medicine
J. Fred Schoellkopf, Jr. Chair in Cardiology Research, Director, Coronary Care Unit and Cardiology Fellowship Program, UT Southwestern Medical Center, Dallas, TX, USA.
See More

  • Comprehensive but concise discussion of the role of biomarkers in heart disease

  • Addresses use of biomarkers in current clinical practice, as well as future indications for clinical practice
  • Sections devoted to biomarkers in ischemic heart disease and heart failure, as well as discussions of biomarkers in screening and biomarkers in the future
  • An essential read for anyone interested in the use of biomarkers in clinical practice
See More
“A vital contribution to a high-interest and emerging field, this comprehensive but concise discussion of the role of biomarkers in contemporary cardiovascular medicine focuses both on indications for biomarkers in current use as well as on new biomarkers. It is an essential read for anyone interested in the use of biomarkers in clinical practice. The quality and content of the book is excellent. It is a valuable resource for cardiovascular physicians, midlevel providers, or students in a rapidly changing field of cardiovascular medicine.” Doodys Reviews<!--end-->
See More
Buy Both and Save 25%!

Biomarkers in Heart Disease (US $147.95)

-and- Metabolic Risk for Cardiovascular Disease (US $142.95)

Total List Price: US $290.90
Discounted Price: US $218.17 (Save: US $72.73)

Buy Both
Cannot be combined with any other offers. Learn more.

Related Titles

Back to Top